HIGHLIGHTS
- What: The aim of this study was to validate the role of previously identified SNPs in predicting resistance to R-CHOP, in an independent suitable case series of DLBCL treated with R-CHOP that the authors enrolled in the framework of a pharmacogenetic stud . This study was performed by using data collected in the previous pharmacogenetic stud . The authors have also shown that the rs1883112 SNP in the NCF4 gene and rs1800871 in the IL10 were able to further discriminate PFS and OS of DLBCL patients belonging to the R-IPI 1-2 subgroup.
- Who . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.